0001209191-20-008293.txt : 20200211
0001209191-20-008293.hdr.sgml : 20200211
20200211161638
ACCESSION NUMBER: 0001209191-20-008293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200207
FILED AS OF DATE: 20200211
DATE AS OF CHANGE: 20200211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jakeman David
CENTRAL INDEX KEY: 0001780556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 20596819
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.,
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-07
0
0001117480
CHIMERIX INC
CMRX
0001780556
Jakeman David
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
0
1
0
0
Principal Accounting Officer
Common Stock
2020-02-07
4
S
0
2290
1.70
D
87876
D
The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 24, 2017, January 25, 2018 and January 23, 2019.
/s/ Michael Alrutz, Attorney-in-Fact
2020-02-10